三七与人参化学成分、药理活性及作用机制对比分析OA
Comparative Analysis of Chemical Components,Pharmacological Activities and Mechanisms of Action between Sanqi(Notoginseng Radix Et Rhizoma)and Renshen(Ginseng Radix Et Rhizoma)
三七具有散瘀、止血、定痛功效,在心血管疾病及止血领域优势突出,其特有的三七素是关键止血活性成分;人参被誉为"百草之王",具有大补元气及适应原样作用,在抗疲劳、免疫调节、认知改善及抗糖尿病等方面药理活性广泛.该文系统梳理了三七与人参在心血管系统、血液系统、抗炎、免疫调节、神经保护、抗肿瘤、抗疲劳及抗糖尿病等领域的药理活性及分子机制,发现尽管三七与人参在抗炎、神经保护、抗肿瘤等作用过程中,均涉及核因子κB(nuclear factor kappa-B,NF-κB)、磷脂酰肌醇3-激酶/蛋白激酶B(phosphoinositide 3-kinase/protein kinase B,PI3K/Akt)、丝裂原活化蛋白激酶(mitogen-activated protein kinase,MAPK)等共同分子通路,但主要活性成分的含量差异及特有成分的存在,决定了其临床应用侧重.此外,传统炮制方法,如蒸制可显著促进三七与人参化学成分转化并增强药效.该文通过深入解析三七与人参的药用价值,旨在为临床合理用药及新药研发提供科学依据与理论参考.
Sanqi(Notoginseng Radix Et Rhizoma)is renowned for its effects of"dispersing blood stasis,stopping bleeding,and relieving pain",with outstanding advantages in cardiovascular diseases and hemostasis,and its unique dencichine is a key hemostatic active component.Renshen(Ginseng Radix Et Rhizoma),known as the"king of herbs",is famous for its properties of"greatly tonifying primordial qi"and adaptogenic characteristics,and has extensive pharmacological activities in anti-fatigue,immune regulation,cognitive improvement,and anti-diabetes.This article systematically reviews the pharmacological activities and molecular mechanisms of the two in cardiovascular,hematological,anti-inflammatory,immune regulation,neuroprotection,anti-tumor,anti-fatigue,and anti-diabetes fields.It is found that although both involve common molecular pathways such as nuclear factor kappa-B(NF-κB),phosphoinositide 3-kinase/protein kinase B(PI3K/Akt),and mitogen-activated protein kinase(MAPK)in anti-inflammatory,neuroprotective,and anti-tumor processes,the differences in the content of main active components and the existence of unique components determine their clinical application emphases.In addition,traditional processing methods,such as steaming,can significantly promote the transformation of chemical components and enhance the efficacy of both.This article aims to provide a scientific basis and theoretical reference for rational clinical use and new drug development by deeply analyzing the medicinal values of P.Sanqi(Notoginseng Radix Et Rhizoma)and Renshen(Ginseng Radix Et Rhizoma).
莫思平;刘菲菲;黄婧;郝二伟;侯小涛;邓家刚;杜正彩
广西中医药大学,广西 南宁 530200||广西中医药壮瑶医药研究院,广西 南宁 530200||广西中药药效研究重点实验室,广西 南宁 530200广西中医药大学,广西 南宁 530200||广西中医药壮瑶医药研究院,广西 南宁 530200||广西中药药效研究重点实验室,广西 南宁 530200广西中医药大学,广西 南宁 530200||广西中医药壮瑶医药研究院,广西 南宁 530200||广西中药药效研究重点实验室,广西 南宁 530200广西中医药壮瑶医药研究院,广西 南宁 530200||广西中药药效研究重点实验室,广西 南宁 530200||广西中医湿病方药理论与转化重点实验室,广西 南宁 530200广西中医药壮瑶医药研究院,广西 南宁 530200||广西中药药效研究重点实验室,广西 南宁 530200||中药资源循环利用广西高校工程研究中心,广西 南宁 530200广西中医药壮瑶医药研究院,广西 南宁 530200||广西中药药效研究重点实验室,广西 南宁 530200||广西中医湿病方药理论与转化重点实验室,广西 南宁 530200广西中医药大学,广西 南宁 530200||广西中医药壮瑶医药研究院,广西 南宁 530200||广西中药药效研究重点实验室,广西 南宁 530200||广西中医湿病方药理论与转化重点实验室,广西 南宁 530200
医药卫生
三七人参化学成分药理机制对比分析
Sanqi(Notoginseng Radix Et Rhizoma)Renshen(Ginseng Radix Et Rhizoma)chemical componentspharmacological mechanismscomparative analysis
《辽宁中医药大学学报》 2026 (9)
44-51,8
国家自然科学基金项目(82060742)
评论